APUS insider transaction filings
Apimeds Pharmaceuticals US, Inc. — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-11-21. Screen APUS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-11-21 | 4/A | Inscobee Inc. — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2025-11-13 | 4 | Koo Jakap — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Yoon Hankil — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Weintraub Bennett — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Kogan Elona — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | O'DONNELL CAROL A — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | Kogan Elona — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | O'DONNELL CAROL A — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Koo Jakap — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Yoon Hankil — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Weintraub Bennett — Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Kim Christopher — Chairman and CMO, Director | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Emerson Erik C. — Chief Executive Officer, Director | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4/A | Inscobee Inc. — 10% owner | Conversion (C): 71,090 @ $2.60 · Conversion (C): 44,041 @ $2.60 · Conversion (C) @ $0 · Conversion (C) @ $0 | EDGAR |
| 2025-05-20 | 4 | Koo Jakap — Director | Grant/award (A): 5,780 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Weintraub Bennett — Director | Grant/award (A): 5,780 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Yoon Hankil — Director | Grant/award (A): 5,780 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Kim Christopher — Chairman and CMO, Director | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2025-05-20 | 4 | Emerson Erik C. — Chief Executive Officer, Director | Grant/award (A): 750,000 @ $0 · Grant/award (A): 347,279 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Kogan Elona — Director | Grant/award (A): 5,780 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | O'DONNELL CAROL A — Director | Grant/award (A): 5,780 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Kim Christopher — Chairman and CMO, Director | Purchase (P): 19,770 @ $1.82 · Purchase (P): 7,730 @ $1.86 | EDGAR |
| 2025-05-14 | 4 | Koo Jakap — Director | Purchase (P): 28,500 @ $1.99 | EDGAR |
| 2025-05-14 | 4 | Inscobee Inc. — 10% owner | Purchase (P): 500,000 @ $4 · Conversion (C): 182,002 @ $2.60 · Conversion (C): 71,090 @ $2.60 · Conversion (C): 44,041 @ $2.60 · Conversion (C) @ $0 · Conversion (C) @ $0 · +1 more | EDGAR |
Recent 8-K events — Apimeds Pharmaceuticals US, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-09 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=APUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →